Research Overview
PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist studied in research models involving melanocortin signaling, neuroendocrine physiology, central nervous system communication, peptide hormone biology, and sexual behavior.
Derived from the melanocortin peptide family, PT-141 has become an important research tool for investigating the neural pathways regulated by melanocortin receptors. Its receptor-selective mechanism has established it as a valuable peptide for exploring the complex relationship between neuroendocrine signaling, behavior, and central nervous system function.
Lyophilized Vial Format
Precision-manufactured and lyophilized for stability, this research-grade peptide is produced to support reproducible laboratory workflows requiring accurate preparation, controlled storage, and consistent experimental performance.
Why Researchers Study PT-141
PT-141 is investigated for its interaction with melanocortin receptors, particularly within the central nervous system, where these pathways contribute to neuroendocrine communication and behavioral regulation. Research continues to examine how modulation of melanocortin signaling influences neuronal activity, peptide hormone interactions, and the molecular mechanisms that coordinate physiological responses through central neural circuits.
Its well-characterized pharmacological profile has made PT-141 a valuable research peptide for studying melanocortin biology, receptor pharmacology, neuroendocrine physiology, and the broader signaling networks involved in central nervous system regulation.
Research Applications
Researchers commonly utilize PT-141 in laboratory investigations involving:
- Melanocortin receptor signaling
- Neuroendocrine physiology
- Central nervous system signaling
- Peptide hormone biology
- Receptor pharmacology
- Behavioral neuroscience
- Neuronal communication
- Endocrine signaling
- Melanocortin biology
- Experimental neuroscience
